Literature DB >> 9739994

Expression of the ataxia-telangiectasia gene (ATM) product in human cerebellar neurons during development.

A Oka1, S Takashima.   

Abstract

Ataxia-telangiectasia (A-T) is a hereditary disorder, exhibiting progressive cerebellar ataxia. We investigated the expression of the ATM protein in the human CNS. By western blotting, the ATM protein was detected in the cerebellar cortex, but not in the cerebral cortex, at the late gestational stage. Immunohistochemistry revealed that cerebellar neurons, particularly Purkinje cells, were markedly immunoreactive during late prenatal and early postnatal periods, followed by persistent and moderate reactivity in Purkinje cells. The ATM protein was distributed within the cytoplasm of Purkinje cells, but not within the nuclei. The ATM protein seems to play a role as a cytoplasmic protein in neurons of the cerebellar cortex.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9739994     DOI: 10.1016/s0304-3940(98)00576-x

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  24 in total

Review 1.  The pathogenesis of ataxia-telangiectasia. Learning from a Rosetta Stone.

Authors:  R A Gatti; S Becker-Catania; H H Chun; X Sun; M Mitui; C H Lai; N Khanlou; M Babaei; R Cheng; C Clark; Y Huo; N C Udar; R K Iyer
Journal:  Clin Rev Allergy Immunol       Date:  2001-02       Impact factor: 8.667

Review 2.  Radiological imaging in ataxia telangiectasia: a review.

Authors:  Ishani Sahama; Kate Sinclair; Kerstin Pannek; Martin Lavin; Stephen Rose
Journal:  Cerebellum       Date:  2014-08       Impact factor: 3.847

3.  ATM is a cytoplasmic protein in mouse brain required to prevent lysosomal accumulation.

Authors:  C Barlow; C Ribaut-Barassin; T A Zwingman; A J Pope; K D Brown; J W Owens; D Larson; E A Harrington; A M Haeberle; J Mariani; M Eckhaus; K Herrup; Y Bailly; A Wynshaw-Boris
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-18       Impact factor: 11.205

4.  Differential localization of ATM is correlated with activation of distinct downstream signaling pathways.

Authors:  Angela Alexander; Cheryl L Walker
Journal:  Cell Cycle       Date:  2010-09-05       Impact factor: 4.534

5.  Dexamethasone partially rescues ataxia telangiectasia-mutated (ATM) deficiency in ataxia telangiectasia by promoting a shortened protein variant retaining kinase activity.

Authors:  Michele Menotta; Sara Biagiotti; Marzia Bianchi; Luciana Chessa; Mauro Magnani
Journal:  J Biol Chem       Date:  2012-10-10       Impact factor: 5.157

6.  A novel porcine model of ataxia telangiectasia reproduces neurological features and motor deficits of human disease.

Authors:  Rosanna Beraldi; Chun-Hung Chan; Christopher S Rogers; Attila D Kovács; David K Meyerholz; Constantin Trantzas; Allyn M Lambertz; Benjamin W Darbro; Krystal L Weber; Katherine A M White; Richard V Rheeden; Michael C Kruer; Brian A Dacken; Xiao-Jun Wang; Bryan T Davis; Judy A Rohret; Jason T Struzynski; Frank A Rohret; Jill M Weimer; David A Pearce
Journal:  Hum Mol Genet       Date:  2015-09-15       Impact factor: 6.150

7.  Cytoplasmic ATM in neurons modulates synaptic function.

Authors:  Jiali Li; Yu R Han; Mark R Plummer; Karl Herrup
Journal:  Curr Biol       Date:  2009-12-03       Impact factor: 10.834

Review 8.  Pathogenesis of ataxia-telangiectasia: the next generation of ATM functions.

Authors:  Mark Ambrose; Richard A Gatti
Journal:  Blood       Date:  2013-02-25       Impact factor: 22.113

9.  Oxidative stress is responsible for deficient survival and dendritogenesis in purkinje neurons from ataxia-telangiectasia mutated mutant mice.

Authors:  Philip Chen; Cheng Peng; John Luff; Kevin Spring; Dianne Watters; Steven Bottle; Shigeki Furuya; Martin F Lavin
Journal:  J Neurosci       Date:  2003-12-10       Impact factor: 6.167

Review 10.  Do all of the neurologic diseases in patients with DNA repair gene mutations result from the accumulation of DNA damage?

Authors:  P J Brooks; Tsu-Fan Cheng; Lori Cooper
Journal:  DNA Repair (Amst)       Date:  2008-03-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.